Legend Biotech Corporation

10/14/2025 | Press release | Distributed by Public on 10/14/2025 06:01

Legend Biotech Announces U.S. FDA Approves Label Updates for CARVYKTI® CAR-T Cell Therapy to Include Overall Survival Data (Form 6-K)

Legend Biotech Corporation published this content on October 14, 2025, and is solely responsible for the information contained herein. Distributed via Edgar on October 14, 2025 at 12:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]